18F-FDG PET-CT

DIAGNOSTIC_TEST5 trials

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM), The Netherlands Cancer Institute, Central Hospital, Nancy, France, University Hospital, Brest, Centre Paul Strauss

Conditions

Aortic Valve StenosisCovid-19Diabetic Foot InfectionHER 2 Low-expressing Breast CancerMetastatic Breast CancerNSCLC, Stage IV

Phase 2

Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort

University Hospital, BrestAortic Valve Stenosis

Start: 2022-05-01End: 2024-05-01Target: 100Updated: 2022-04-04

Unknown Phase

Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis

TerminatedNCT03712046

Centre hospitalier de l'Université de Montréal (CHUM)Diabetic Foot Infection

Start: 2019-01-15End: 2019-11-10Updated: 2019-11-13

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

TerminatedNCT04082988

The Netherlands Cancer InstituteNSCLC, Stage IV

Start: 2018-01-23End: 2020-05-22Updated: 2023-10-10

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19

CompletedNCT04764721

Central Hospital, Nancy, FranceCovid-19

Start: 2021-11-17End: 2023-11-27Updated: 2023-11-29

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

Not yet recruitingNCT07130344

Centre Paul StraussHER 2 Low-expressing Breast Cancer, Metastatic Breast Cancer

Start: 2025-09-30End: 2030-09-30Target: 262Updated: 2025-09-10